Unknown

Dataset Information

0

Relative Effectiveness of COVID-19 Vaccination in Healthcare Workers: 3-Dose Versus 2-Dose Vaccination.


ABSTRACT: The omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to have high infectivity and is more likely to evade vaccine immunity. However, booster vaccination is expected to strengthen cross-reactive immunity, thereby increasing the vaccine effectiveness (VE). This study aimed to evaluate the relative VE of the 3-dose (booster) vaccination compared with the 2-dose primary series vaccination in healthcare workers during omicron variant-dominant periods. During the omicron-dominant period from February 1, 2022 to February 28, 2022, a 1:1 matched case-control study was conducted. Healthcare workers with positive SARS-CoV-2 test results were classified as positive cases, whereas those with negative results served as controls. Compared with the 2-dose primary series vaccination, booster vaccination with mRNA vaccine showed moderate VE (53.1%). However, in multivariate analysis including the time elapsed after vaccination, the significant VE disappeared, reflecting the impact of recent vaccination rather than the third dose itself.

SUBMITTER: Kim SR 

PROVIDER: S-EPMC9444572 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Relative Effectiveness of COVID-19 Vaccination in Healthcare Workers: 3-Dose Versus 2-Dose Vaccination.

Kim Sung Ran SR   Kang Hyeon Jeong HJ   Jeong Hye Rin HR   Jang Su Yeon SY   Lee Jae Eun JE   Kim Da Eun DE   Lee Hae Ry HR   Cho Min Hee MH   Noh Ji Yun JY   Cheong Hee Jin HJ   Kim Woo Joo WJ   Song Joon Young JY  

Journal of Korean medical science 20220905 35


The omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to have high infectivity and is more likely to evade vaccine immunity. However, booster vaccination is expected to strengthen cross-reactive immunity, thereby increasing the vaccine effectiveness (VE). This study aimed to evaluate the relative VE of the 3-dose (booster) vaccination compared with the 2-dose primary series vaccination in healthcare workers during omicron variant-dominant periods. During th  ...[more]

Similar Datasets

2023-03-20 | E-MTAB-12829 | biostudies-arrayexpress
| S-BSST563 | biostudies-other
| S-EPMC9586956 | biostudies-literature
| S-EPMC9979693 | biostudies-literature
| S-EPMC9628206 | biostudies-literature
| S-EPMC8364953 | biostudies-literature
| S-EPMC10891992 | biostudies-literature
| S-EPMC8503070 | biostudies-literature
| S-EPMC9709452 | biostudies-literature
| S-EPMC9205631 | biostudies-literature